"I think it's the unknowns," Thompson told ESPN on Monday. "It still comes down to effective mitigation of all the risks they're facing. For many weeks, our group has been saying we just don't see a path forward. There are just too many unknowns medically. That is really the focus: the unknowns in the medical world."